Company Filing History:
Years Active: 2010
Title: Meilei Jin: Innovator in Crystalline Lens Diagnosis and Treatment
Introduction
Meilei Jin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of ophthalmology, particularly in the diagnosis and treatment of crystalline lens lesions, such as cataracts. His innovative approach utilizes genetic analysis to improve patient outcomes.
Latest Patents
Meilei Jin holds a patent for a method of diagnosing and treating lesions of the crystalline lens using the human CRYGS gene and its coding product. This patent outlines a method for detecting variations in the crygs gene, transcript, and/or protein in individuals. The presence of such variations indicates a higher likelihood of cataract development compared to normal individuals. Additionally, the patent includes a pharmaceutical composition for treating these lesions.
Career Highlights
Meilei Jin is affiliated with the Chinese Academy of Sciences, where he conducts research and development in the field of genetics and ophthalmology. His work has garnered attention for its potential to revolutionize cataract diagnosis and treatment.
Collaborations
Meilei Jin has collaborated with notable colleagues, including Xiangyin Kong and Lei Bu, to advance research in his field. Their combined expertise has contributed to the development of innovative solutions for eye health.
Conclusion
Meilei Jin's contributions to the diagnosis and treatment of crystalline lens lesions highlight his role as a leading inventor in ophthalmology. His work not only enhances understanding of cataract development but also paves the way for improved therapeutic options.